ARCHIVES

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

DCT Advisors Approve Five Trials For High Priority Status

April 7, 1995

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

Competing Strategies For Breast Cancer? Brinker Tries to Ensure acceptance Of Report, Visco Urges Broad Effort

October 8, 1993

Advances Found In Treatment Of Aerodigestive Cancers

May 25, 2001

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002